BDBM50291951 (R)-2-(2-Amino-thiazol-4-ylmethyl)-N*1*-((1S,2R,3S)-1-cyclohexylmethyl-2,3-dihydroxy-5-methyl-hexyl)-N*4*-[(methyl-{2-[methyl-(morpholine-4-carbonyl)-amino]-ethyl}-carbamoyl)-methyl]-N*4*-((S)-1-phenyl-ethyl)-succinamide::CHEMBL430781

SMILES CC(C)C[C@H](O)[C@H](O)[C@H](CC1CCCCC1)NC(=O)[C@@H](CC(=O)N(CC(=O)N(C)CCN(C)C(=O)N1CCOCC1)[C@@H](C)c1ccccc1)Cc1csc(N)n1

InChI Key InChIKey=TYLSXDULXDNDBD-NRGLOYHDSA-N

Data  1 Koff  1 Kon

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50291951   

TargetRenin(Homo sapiens (Human))
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50291951((R)-2-(2-Amino-thiazol-4-ylmethyl)-N*1*-((1S,2R,3S...)
Affinity DataKon:  0.00133M-1s-1 Koff:  5.43s-1Assay Description:Component acylation rate constant by the compound against Renin was determinedMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed